Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Shanghai Junshi Bioscience Co., Ltd.
Western Regional Medical Center
University of Louisville
Alliance for Clinical Trials in Oncology
National Cancer Institute, Naples
Ohio State University Comprehensive Cancer Center
Trans Tasman Radiation Oncology Group
Sun Yat-sen University
NYU Langone Health